Key result
Intravascular lithotripsy linked to ~52% lower 1-year MACE vs. rotational atherectomy in tortuous calcified lesions.
Why the study?
Real-world head-to-head evidence comparing the prognostic value of intravascular lithotripsy against standard rotational atherectomy in severely calcified coronary lesions with tortuous or angulated anatomy was lacking.
Does intravascular lithotripsy reduce one-year composite major adverse cardiovascular events compared with rotational atherectomy in patients with severely calcified coronary lesions and concomitant tortuous or angulated anatomy?
Cohort (n=247)
No
Does intravascular lithotripsy reduce one-year composite major adverse cardiovascular events compared with rotational atherectomy in patients with severely calcified coronary lesions and concomitant tortuous or angulated anatomy?
In patients with severely calcified coronary lesions and concomitant tortuous or angulated anatomy, intravascular lithotripsy was associated with a significantly lower risk of one-year MACE compared with rotational atherectomy, driven primarily by reduced heart failure rehospitalization.
Answers are grounded in this paper and cite their sources.
May support intravascular lithotripsy in tortuous calcified lesions; leaves open randomized confirmation before practice change.
Background Intravascular lithotripsy (IVL) is an emerging technique for the treatment of severely calcified coronary lesions, yet head-to-head evidence comparing its prognostic value against standard rotational atherectomy (RA) in real-world practice, particularly in patients with tortuous or angulated coronary anatomy, remains lacking. Methods This retrospective observational cohort study included 247 patients with severely calcified coronary lesions and concomitant tortuous or angulated anatomy who underwent percutaneous coronary intervention between January 2023 and March 2025, comprising 137 patients treated with RA and 110 treated with IVL. The primary endpoint was one-year composite major adverse cardiovascular events (MACE), encompassing all-cause mortality, target vessel revascularization, heart failure rehospitalization, in-stent restenosis, and stroke. Three complementary analytical strategies of escalating robustness, multivariable logistic regression, inverse probability of treatment weighting (IPTW) using a gradient boosted model (GBM), and doubly robust estimation, were employed to estimate the treatment effect of IVL vs. RA. Covariate balance was assessed using standardized mean differences (SMD ≤ 0.10). Results Baseline characteristics were broadly comparable between groups, with significant differences observed only in LDL-C, total cholesterol, and HDL-C (all P < 0.05). After IPTW, all 20 covariates achieved SMD ≤ 0.10. IPTW analysis demonstrated a significant 52% reduction in the odds of MACE with IVL (OR 0.48, 95% CI 0.25–0.90; P < 0.05), with directionally consistent estimates from multivariable logistic regression (OR 0.49, 0.18–1.23; P = 0.14) and doubly robust estimation (OR 0.48, 0.18–1.25; P = 0.13). Among secondary outcomes, one-year heart failure rehospitalization was significantly lower with IVL (OR 0.22, 95% CI 0.03–0.78; P = 0.03); no significant differences were observed for mortality, target vessel revascularization, stroke, or in-stent restenosis. Conclusions In this retrospective cohort of patients with severely calcified coronary lesions, all of whom had concomitant tortuous or angulated anatomy, IVL was associated with a lower risk of one-year MACE compared with RA, an effect driven primarily by a reduction in heart failure rehospitalisation. The consistency across three analytical models suggests robustness of this finding, although confirmation in adequately powered randomised controlled trials is warranted.
No takes yet. Share an insight, caveat, or question.
Kong et al. (2026) conducted a cohort in Severely calcified coronary lesions with concomitant tortuosity or angulation (n=247). Intravascular lithotripsy (IVL) vs. Rotational atherectomy (RA) was evaluated on One-year composite major adverse cardiovascular events (MACE: all-cause mortality, target vessel revascularization, heart failure rehospitalization, in-stent restenosis, and stroke) (OR 0.48, 95% CI 0.25-0.90, p=<0.05). Intravascular lithotripsy was associated with a 52% lower odds of 1-year MACE compared to rotational atherectomy in tortuous or angulated calcified coronary lesions (IPTW OR 0.48, 95% CI 0.25-0.90).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: